First author | Year | Country/Region | Ethnicity | Cancer type | Genotyping method | Age(y) Case/Control | Control source | Case | Control | HWE | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AA | AG | GG | AA | AG | GG | |||||||||
Canzian [14] | 2006 | Europe | Caucasian | Breast cancer | Taqman | 35–69/35–69 | PB | 570 | 212 | 19 | 1060 | 446 | 61 | Y |
Chia [15] | 2008 | USA | Mix | TGCT | Taqman | ≤45/≤45 | PB | 408 | 149 | 16 | 492 | 188 | 23 | Y |
Lonn [16] | 2008 | USA | Mix | Brain tumor | Taqman | ≥18/≥18 | HB | 313 | 97 | 10 | 300 | 103 | 9 | Y |
Ennishi [20] | 2011 | Japan | Asian | Stomach cancer | Taqman | NR | HB | 330 | 293 | 80 | 608 | 637 | 217 | N |
Nakao [21] | 2011 | Japan | Asian | Pancreatic cancer | Taqman | 20–79/20–79 | HB | 70 | 87 | 19 | 580 | 613 | 209 | N |